LMAT LeMaitre Vascular, Inc.

Company profile

• Sector: Healthcare
• Industry: Medical - Instruments & Supplies
• Country: US
• Exchange: NASDAQ
• Employees: 651
• Website: https://www.lemaitre.com

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Latest LMAT news

• 2026-11-05LeMaitre Vascular declares $0.25 dividend Read article
• 2026-11-04LeMaitre Vascular GAAP EPS of $0.65 misses by $0.04, revenue of $68M beats by $0.63M Read article
• 2026-10-12LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026 Read article

Recent dilution filers

• AIOK — AI OKTO CORP.
• AIRE — reAlpha Tech Corp.
• ANVS — Annovis Bio, Inc.
• ARQT — Arcutis Biotherapeutics, Inc.
• BOSC — B.O.S. Better Online Solutions Ltd.
• CODX — Co-Diagnostics, Inc.

Related companies

• ISRG — Intuitive Surgical, Inc.
• BDX — Becton, Dickinson and Company
• ALC — Alcon Inc.
• MDLN — Medline Inc.
• RMD — ResMed Inc.
• WST — West Pharmaceutical Services, Inc.